SHILPAMED.NSSHILPAMED.NSNSE
Loading
ROE: Returns DecliningContracting
Percentile Rank14
3Y CAGR-0.3%
5Y CAGR-22.4%
Year-over-Year Change
Return on equity
3Y CAGR
-0.3%/yr
vs -23.5%/yr prior
5Y CAGR
-22.4%/yr
Recent acceleration
Acceleration
+23.2pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.30% | +87.3% |
| 2024 | 1.76% | +196.6% |
| 2023 | -1.82% | -154.8% |
| 2022 | 3.33% | -66.7% |
| 2021 | 9.99% | -14.9% |
| 2020 | 11.75% | +25.3% |
| 2019 | 9.37% | -3.4% |
| 2018 | 9.70% | -11.0% |
| 2017 | 10.90% | -28.6% |
| 2016 | 15.26% | - |